Innate and adaptive immune responses in HCV infections (Q26851685)

title

Innate and adaptive immune responses in HCV infections (English)

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Robert Thimme

series ordinal

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

1 reference

November 2014

1 reference

published in

Journal of Hepatology

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

61

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

S14-25

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1 Suppl

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer cells in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Type I interferons in host defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Acute hepatitis C: current status and remaining challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-lambda serum levels in hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

NK cells in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Restoration of HCV-specific CD8+ T cell function by interferon-free therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

A haplotype map of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Activation of natural killer cells during acute infection with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

A view to natural killer cells in hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Epidemiology of viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Neutralizing antibody response during acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Function of RIG-I-like receptors in antiviral innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

CD8 Epitope Escape and Reversion in Acute HCV Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Immune evasion versus recovery after acute hepatitis C virus infection from a shared source

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Compromised function of natural killer cells in acute and chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Natural killer cells in viral hepatitis: facts and controversies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

The global burden of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Failure of innate and adaptive immune responses in controlling hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Immunology. An interferon paradox

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

T cell responses in hepatitis C: the good, the bad and the unconventional

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

NKp46+ expression on NK cells as a biomarker for liver pathology and IFN-responiveness in HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Emerging concepts in immunity to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

SOCS proteins: negative regulators of cytokine signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.JHEP.2014.06.035

7 January 2021

10.1016/J.JHEP.2014.06.035

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1616720

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json

release_a26kanlwyzeihppirzq2h5x5py

10 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a26kanlwyzeihppirzq2h5x5py

24 November 2022

mapped directly with Wikidata item

1616720

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

1616720

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25443342%20AND%20SRC:MED&resulttype=core&format=json